Patient-reported outcomes with CAR T-cell therapy

Tandem 2025: Study Evaluates Patient, Caregiver Experiences With CAR-T TherapyПодробнее

CAR-T in B-cell lymphomas: long-term outcomes, risk of dropout, and late effectsПодробнее

The potential impact of ICANS on long-term cognition in patients with DLBCL who have received CAR-TПодробнее

Clinical outcomes of patients with R/R B-cell ALL receiving CAR-TПодробнее

CAR T-Cell Therapy | Transforming Myeloma Patient CareПодробнее

Evolve | What You Should Know About Advances in CAR T-Cell Therapy for MyelomaПодробнее

CAR-T Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscapeПодробнее

What’s New In Mantle Cell Lymphoma: Updates from ASCO 2024 & the EHA Hybrid CongressПодробнее

S2 Episode 2: What Do We Know About Quality of Life and Patient-Reported Outcomes After Transplan...Подробнее

Idecabtagene Vicleucel for High-Risk Early Relapse Multiple Myeloma - KarMMa-2 StudyПодробнее

Module 2: Toxicity Assessment and Management | Early & Late Side EffectsПодробнее

CILTA-CEL | BCMA CAR T Cell for Early Lines of Therapy in Myeloma- CARTITUDE 4Подробнее

Transplant and CAR T-cell Therapy for Older AdultsПодробнее

IACH Post EBMT 2024Подробнее

Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Soc...Подробнее

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Da...Подробнее

An insight into the myeloma patient perspective on PROs in CAR-T clinical trialsПодробнее

Managing the practicalities of CAR T-cell therapies in patients with R/R MCLПодробнее

Trial of an Education Video for CAR T-cell Therapy Recipients | P. Connor Johnson | ASH 2023Подробнее

CAR T-Cell in Lymphoma - Dr. Anna Sureda (June 3-4, 2022)Подробнее